查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1978208

全球血小板浓缩血浆和干细胞脱髮症治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计富血小板血浆 (PRP) 和干细胞脱髮症治疗的市场规模将从 2025 年的 4.9736 亿美元增长到 2034 年的 8.094 亿美元，2026 年至 2034 年的复合年增长率为 5.56%。

受脱髮症盛行率上升和人们美容意识增强的推动，富血小板血浆（PRP）和干细胞脱髮症治疗的全球市场正经历强劲增长。 PRP和干细胞疗法等非手术再生医学因其微创性和良好的治疗效果而日益受到欢迎。美容手术需求的不断增长也显着促进了市场成长。

关键成长要素包括再生医学技术的进步和专业诊所的增加。可支配收入的成长和社群媒体的影响力正在推动对个人化脱髮治疗方案的需求成长。干细胞疗法的持续研究正在提高治疗效果和安全性，进一步增强了市场需求。

展望未来，随着个人化再生医学疗法的日益普及，市场预计将持续成长。皮肤科医师对该疗法的接受度不断提高，以及临床证据的不断积累，都将为这一增长提供支持。在新兴市场，医疗旅游和美容诊所的扩张带来了巨大的发展机会。总体而言，再生医学领域的创新有望推动市场的长期发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球血小板浓缩血浆和干细胞脱髮症治疗市场：依治疗方法

  • 市场分析、洞察与预测
  • 富血小板血浆疗法
  • 干细胞疗法（骨髓来源、脂肪来源）

第五章 全球血小板浓缩血浆和干细胞脱髮症治疗市场：按适应症划分

  • 市场分析、洞察与预测
  • 雄性脱髮症
  • 先天性脱髮症
  • 瘢痕脱髮症
  • 其他的

第六章 全球血小板浓缩血浆和干细胞脱髮症治疗市场：按最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 皮肤科诊所
  • 其他的

第七章 全球血小板浓缩血浆和干细胞脱髮症治疗市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Kerastem
    • Eclipse
    • Regen Lab SA
    • Restore Hair
    • RepliCel Life Sciences
    • Histogen Inc
    • Glofinn Oy
    • ACell Inc
    • HairClone Ltd
    • Follica Inc
简介目录
Product Code: VMR112114204

The Platelet Rich Plasma and Stem Cell Alopecia Treatment Market size is expected to reach USD 809.40 Million in 2034 from USD 497.36 Million (2025) growing at a CAGR of 5.56% during 2026-2034.

The Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market is witnessing strong growth due to increasing prevalence of hair loss conditions and rising aesthetic awareness. Non-surgical regenerative therapies such as PRP and stem cell treatments are gaining popularity for their minimally invasive nature and promising results. Growing demand for cosmetic procedures is significantly boosting market expansion.

Key growth drivers include technological advancements in regenerative medicine and increasing availability of specialized clinics. Rising disposable incomes and social media influence are encouraging individuals to seek hair restoration solutions. Continuous research in stem cell therapy is improving treatment efficacy and safety profiles, further strengthening market demand.

Looking ahead, the market is expected to expand with greater adoption of personalized regenerative treatments. Increasing acceptance among dermatologists and improved clinical evidence will support growth. Emerging markets present significant opportunities due to expanding medical tourism and aesthetic clinics. Overall, innovation in regenerative therapies will drive long-term market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment

  • Platelet Rich Plasma Therapy
  • Stem Cell Therapy (Bone Marrow, Adipose)

By Indication

  • Androgenic Alopecia
  • Congenital Alopecia
  • Cicatricial or Scarring Alopecia
  • Others

By End-user

  • Hospitals
  • Dermatology Clinics
  • Others

COMPANIES PROFILED

  • Kerastem, Eclipse, Regen Lab SA, Restore Hair, RepliCel Life Sciences, Histogen Inc, Glofinn Oy, ACell Inc, HairClone Ltd, Follica Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET: BY TREATMENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Treatment
  • 4.2. Platelet Rich Plasma Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Stem Cell Therapy (Bone Marrow, Adipose) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET: BY INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Indication
  • 5.2. Androgenic Alopecia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Congenital Alopecia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Cicatricial or Scarring Alopecia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Dermatology Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Treatment
    • 7.2.2 By Indication
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Treatment
    • 7.3.2 By Indication
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Treatment
    • 7.4.2 By Indication
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Treatment
    • 7.5.2 By Indication
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Treatment
    • 7.6.2 By Indication
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Kerastem
    • 9.2.2 Eclipse
    • 9.2.3 Regen Lab SA
    • 9.2.4 Restore Hair
    • 9.2.5 RepliCel Life Sciences
    • 9.2.6 Histogen Inc
    • 9.2.7 Glofinn Oy
    • 9.2.8 ACell Inc
    • 9.2.9 HairClone Ltd
    • 9.2.10 Follica Inc